Foresite Capital is lucky to have a man as founder and CEO who can help the firm live up to its name. He is Jim Tananbaum and since 2011 the private equity firm has been specializing in identifying upcoming leaders in the healthcare industry who have the foresight and skills to grow profitably with a little help to help things move faster and smoother. That is what the firm does as they supply everything from capital; networks and information as they attempt to help those emerging plays get headed in the right direction.
It is a strategy that works and has been paying dividends for those at Foresite Capital and investors who want to be in on the healthcare action. Jim Tananbaum’s previous experience makes him uniquely suited to hold the leadership role there. As co-founder of two biopharmaceutical companies and two healthcare investment practices he has a lot of experience making effective decisions that should help the newer private equity firm stand out among others looking to catch a piece of the same market share.
Today that single drug alone is looking to grab over $1 billion in annual revenue, and so the evidence speaks for itself that Jim Tananbaum knows how to choose his plays wisely and invest in them appropriately. He understands that it takes not only a nice amount of capital in order to bring ideas to life, but also that it requires the ability to engage the brightest thought leaders in the healthcare industry. He has continued to do just that through the Foresite firm as well.
He is currently looking at people and companies that are using data science and deep learning in order to revolutionize tissue and blood/saliva sequencing for purposes of disease prevention and other similar ventures. Genomic sequencing is going to explode in the near future as tech minds get together with some of the top healthcare scientists, and Jim Tananbaum wants to be there when it happens. You can visit his About.me page to know more.
See more: https://ideamensch.com/jim-tananbaum/